ORS-ISFR 17th International Biennial Meeting

项目总结 每年有2500多万美国人发生骨折，其中很大一部分是骨折 无法治愈。骨折愈合延迟或失败是导致患者残疾的主要原因 和成本。因此，迫切需要更好地了解骨愈合的生物学，并利用这一点 开发新的诊断和治疗方法的知识。我们正在寻求对第17届双年度会议的支持。 国际骨折修复科(ISFR)。2017年，ISFR被纳入为 整形外科研究学会(ORS)，从而利用最大的科学组织的外联 在世界上致力于骨科研究。ISFR致力于推动和交流 最新的关于骨折修复的科学思想和研究成果及其在改善骨折修复中的应用 病人护理。我们的使命是成为整合和展示与临床相关的前沿想法的首要论坛， 骨折愈合的翻译性、基础性科学研究。组织主题为“跨学科” 科学“，会议将集中在从细胞到患者范围内对机械生物学的最新理解 以及它在骨骼修复中的作用；设备开发的商业考虑和翻译长凳上的想法 以及个性化再生疗法和相关的先进技术(即，治疗学， 芯片上的器官，与免疫系统相互作用)。为了增加临床参与度，双年展 ISFR会议将在国际矫形外科联合研究会(ICORs)第30届会议之前举行 周年纪念世界大会。ICORs世界大会项目由欧洲ORS(Eors)联合主办， 英国ORS(BORS)和AO研究所达沃斯。催化ISFR和ISFR之间的异花授粉 这些协会，我们会议的第二天(9月7日)被设计为一个临床桥梁日，在那里 ISFR和ICORs成员都可以参加。总共，我们将邀请2位主讲嘉宾，20场特邀会议 演讲者和15个摘要精选的讲台演讲。我们预计还会有30-40篇摘要入选 就像海报一样。会议将介绍关于骨折愈合基础生物学的最新研究成果 研究和前瞻性临床研究。该计划委员会高度专注于促进包容性 环境。外科医生、生物学家、工程师和政策制定者将出席会议，并从 学术界、政府和工业界。各种活动将侧重于职业发展和 为骨愈合领域的实习生建立关系网。

PROJECT SUMMARY Bone fractures occur in more than 25 million Americans per year, and a significant percentage of those fractures fail to heal. Fractures that show delayed or failed progression to heal account for the majority of patient disability and costs. Thus, there is an urgent need to better understand the biology of bone healing, and to use that knowledge to develop new diagnostics and therapeutics. We are seeking support for the 17th Biennial conference of the International Section of Fracture Repair (ISFR). In 2017, the ISFR was incorporated as a section within the Orthopaedic Research Society (ORS), thereby leveraging the outreach of the largest scientific organization in the world dedicated to orthopaedic research. The ISFR is dedicated to the advancement and exchange of the most current scientific ideas and research findings on fracture repair and its application to the improvement of patient care. Our mission is be the premier forum to integrate and present cutting-edge ideas related to clinical, translational, and basic science research of fracture healing. With an organizational theme of “Transdisciplinary Science”, sessions will focus on the newest understanding of mechanobiology from the cellular to patient scale and its role in bone repair; commercial considerations for device development and translating ideas from bench to market; and personalized regenerative therapies and associated advanced technologies (i.e., therapeutics, organ-on-a-chip, interplay with the immune system). In an effort to increase clinical participation, the Biennial ISFR Meeting will be held just prior to the International Combined Orthopaedic Research Societies (ICORS) 30th Anniversary World Congress. The ICORS World Congress program is co-hosted by the European ORS (EORS), British ORS (BORS), and AO Research Institute Davos. To catalyze cross-pollination between the ISFR and these societies, the second day of our meeting (September 7th) has been designed as a clinical bridge day where both ISFR and ICORS members can attend. In total, we will have 2 invited keynote speakers, 20 invited session speakers, and 15 abstract-selected podium presentations. We anticipate an additional 30-40 abstracts selected as posters. The meeting will present the most up to date research on fracture healing basic biology, translational research, and prospective clinical studies. The Program Committee is highly focused on fostering an inclusive environment. Surgeons, biologists, engineers, and policy makers will attend the meeting and be drawn from academia, government, and industry. A variety of activities will be focused on career development and networking for trainees in the bone healing field.